United States Biotechnology & Medical Research

Bio-Techne Corporation (TECH)

Track

Track

Bio-Techne Corp has seen no insider trading activity within the last three months. The most recent transactions occurred on May 8, 2026, involving sales by directors and other personnel. These historical divestments represent the final recorded movements by company leadership prior to the current period.
Ticker: TECH Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bio-Techne Corporation. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.2
Herr Amy E. Non-Executive Director
Transaction date
Sale
Price
62.17
Quantity 13,441 +25.1%
Value US$3,566,371
2.2
JOSHUA MOLHO Director Non-Executive Director
Transaction date
Proposed sale
Price
183.33
Quantity 70,690
Value US$3,652,312
2.2
Herr Amy E. Non-Executive Director
Transaction date
Sale
Price
172.89
Quantity 50,417 -6.3%
Value US$3,297,005
2.2
JOSHUA MOLHO Director Non-Executive Director
Transaction date
Proposed sale
Price
59.11
Quantity 1,976
Value US$116,791
3.0
Nusse Roeland Non-Executive Director
Transaction date
Sale
Price
56.36
Quantity 17,040 -27.7%
Value US$960,388
1.7
BAUMGARTNER ROBERT V Non-Executive Director
Transaction date
Sale
Price
56.21
Quantity 17,040 -27.5%
Value US$957,818
3.0
ROELAND NUSSE Director Non-Executive Director
Transaction date
Proposed sale
Price
56.36
Quantity 17,040
Value US$960,388
2.2
Herr Amy E. Non-Executive Director
Transaction date
Sale
Price
49.77
Quantity 1,280 -39.3%
Value US$63,705
2.2
JOSHUA MOLHO Officer Officer
Transaction date
Proposed sale
Price
49.77
Quantity 1,280
Value US$63,705
2.2
Herr Amy E. Non-Executive Director
Transaction date
Sale
Price
65.96
Quantity 1,860 -48.5%
Value US$122,691
2.2
JOSHUA MOLHO Domestic Partner of Director Non-Executive Director
Transaction date
Proposed sale
Price
65.96
Quantity 1,860
Value US$122,691
3.7
Kelderman Kim Chief Executive Officer Executive Director
Transaction date
Sale
Price
77.95
Quantity 1,661 -4.1%
Value US$129,480
3.7
Kelderman Kim Chief Executive Officer Executive Director
Transaction date
Sale
Price
77.19
Quantity 11,731 -22.4%
Value US$905,533
3.7
KIM KELDERMAN Director; Officer Executive Director
Transaction date
Proposed sale
Price
77.05
Quantity 13,392
Value US$1,031,854
1.7
BAUMGARTNER ROBERT V Non-Executive Director
Transaction date
Sale
Price
72.10
Quantity 16,000 -26.9%
Value US$1,153,664
1.7
ROBERT V. BAUMGARTNER Director Non-Executive Director
Transaction date
Proposed sale
Price
72.10
Quantity 16,000
Value US$1,153,664
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
83.84
Quantity 4,000 -9.9%
Value US$335,377
3.4
JOHN L HIGGINS Director Non-Executive Director
Transaction date
Proposed sale
Price
83.84
Quantity 4,000
Value US$335,377
3.0
Nusse Roeland Non-Executive Director
Transaction date
Sale
Price
76.98
Quantity 10,400 -19.4%
Value US$800,627
3.0
Nusse Roeland Director Non-Executive Director
Transaction date
Proposed sale
Price
76.98
Quantity 10,400
Value US$800,626
3.0
Nusse Roeland Non-Executive Director
Transaction date
Sale
Price
80.32
Quantity 8,939 -14.7%
Value US$717,959
3.0
ROELAND NUSSE Director Non-Executive Director
Transaction date
Proposed sale
Price
80.32
Quantity 8,939
Value US$717,959
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
88.36
Quantity 80,000 -6.0%
Value US$7,069,024
2.8
Kummeth Charles R. Officer Officer
Transaction date
Proposed sale
Price
88.36
Quantity 80,000
Value US$7,069,024
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Sale
Price
83.00
Quantity 322 -0.0%
Value US$26,726
2.8
Charles Kummeth Officer Officer
Transaction date
Proposed sale
Price
83.00
Quantity 50,000
Value US$4,150,000
2.8
Furlow Brenda S. SVP - GENERAL COUNSEL Officer
Transaction date
Sale
Price
82.12
Quantity 7,450 -22.2%
Value US$611,810
2.8
Furlow Brenda S. SVP - GENERAL COUNSEL Officer
Transaction date
Sale
Price
82.01
Quantity 800 -3.0%
Value US$65,605
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
380.71
Quantity 8 -0.1%
Value US$3,046
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
385.47
Quantity 504 -8.4%
Value US$194,277
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
380.15
Quantity 992 -14.2%
Value US$377,112
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
374.90
Quantity 100 -1.4%
Value US$37,490
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
373.99
Quantity 900 -11.2%
Value US$336,593
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
366.09
Quantity 600 -11.5%
Value US$219,654
2.8
Kummeth Charles R. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
365.00
Quantity 5,104 -2.5%
Value US$1,862,960
3.4
HIGGINS JOHN L Non-Executive Director
Transaction date
Sale
Price
364.31
Quantity 1,000 -17.8%
Value US$364,310
1.7
BAUMGARTNER ROBERT V Non-Executive Director
Transaction date
Purchase
Price
352.55
Quantity 300 +3.1%
Value US$105,765
3.7
Kelderman Kim Pres. Diagnostics & Genom Officer
Transaction date
Sale
Price
505.78
Quantity 400 -100.0%
Value US$202,313
3.7
Kelderman Kim Pres. Diagnostics & Genom Officer
Transaction date
Sale
Price
503.76
Quantity 100 -20.0%
Value US$50,376
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
506.24
Quantity 401 -23.3%
Value US$203,002
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
505.49
Quantity 2,535 -59.6%
Value US$1,281,407
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
504.39
Quantity 8,989 -67.9%
Value US$4,533,985
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
503.61
Quantity 9,043 -40.6%
Value US$4,554,137
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
502.77
Quantity 4,054 -15.4%
Value US$2,038,221
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
505.01
Quantity 400 -1.5%
Value US$202,002
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
504.14
Quantity 537 -2.0%
Value US$270,725
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
502.99
Quantity 300 -1.1%
Value US$150,897
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
504.78
Quantity 200 -0.7%
Value US$100,956
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
504.09
Quantity 700 -2.5%
Value US$352,860
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
525.10
Quantity 200 -1.8%
Value US$105,020
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
528.55
Quantity 943 -8.1%
Value US$498,427
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
527.50
Quantity 1,433 -10.9%
Value US$755,903
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
526.50
Quantity 2,880 -18.0%
Value US$1,516,321
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
525.61
Quantity 3,566 -18.2%
Value US$1,874,318
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
525.23
Quantity 662 -5.8%
Value US$347,704
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Planned sale
Price
525.18
Quantity 100 -0.9%
Value US$52,518
3.6
Eansor Norman David President-Protein Sciences Officer
Transaction date
Sale
Price
503.07
Quantity 1,538 -53.9%
Value US$773,728
2.8
Furlow Brenda S. SVP - General Counsel Officer
Transaction date
Sale
Price
506.12
Quantity 3,108 -29.0%
Value US$1,573,011
2.8
Furlow Brenda S. SVP - General Counsel Officer
Transaction date
Sale
Price
505.26
Quantity 1,569 -12.8%
Value US$792,755
2.8
Furlow Brenda S. SVP - General Counsel Officer
Transaction date
Sale
Price
503.24
Quantity 323 -2.6%
Value US$162,546
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
484.98
Quantity 300 -2.7%
Value US$145,494
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
483.62
Quantity 300 -2.6%
Value US$145,085
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
481.61
Quantity 300 -2.6%
Value US$144,482
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
480.66
Quantity 700 -5.6%
Value US$336,462
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
480.70
Quantity 100 -0.8%
Value US$48,070
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
479.96
Quantity 1,300 -9.4%
Value US$623,954
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
478.58
Quantity 1,800 -11.5%
Value US$861,444
2.4
Hippel James Chief Financial Officer Officer
Transaction date
Sale
Price
477.69
Quantity 5,200 -24.9%
Value US$2,484,002
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
450.37
Quantity 326 -0.2%
Value US$146,821
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
449.09
Quantity 2,583 -1.6%
Value US$1,159,999
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
452.13
Quantity 109 -0.1%
Value US$49,282
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
451.54
Quantity 1,050 -0.7%
Value US$474,117
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
450.39
Quantity 1,698 -1.1%
Value US$764,762
2.8
Kummeth Charles R. Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
449.35
Quantity 6,732 -4.0%
Value US$3,025,024
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-12 2026-05-08 S Sale
2.2
Herr Amy E.
Non-Executive Director
13,441 +25.1%
62.17
US$3,566,371 		13,441 +25.1% 62.17 US$3,566,371
2026-05-08 2026-05-08 PrS Proposed sale
2.2
JOSHUA MOLHO

Director

Non-Executive Director
70,690
183.33
US$3,652,312 		70,690 183.33 US$3,652,312
2026-02-19 2026-02-17 S Sale
2.2
Herr Amy E.
Non-Executive Director
50,417 -6.3%
172.89
US$3,297,005 		50,417 -6.3% 172.89 US$3,297,005
2026-02-17 2026-02-17 PrS Proposed sale
2.2
JOSHUA MOLHO

Director

Non-Executive Director
1,976
59.11
US$116,791 		1,976 59.11 US$116,791
2025-08-27 2025-08-25 S Sale
3.0
Nusse Roeland
Non-Executive Director
17,040 -27.7%
56.36
US$960,388 		17,040 -27.7% 56.36 US$960,388
2025-08-27 2025-08-25 S Sale
1.7
BAUMGARTNER ROBERT V
Non-Executive Director
17,040 -27.5%
56.21
US$957,818 		17,040 -27.5% 56.21 US$957,818
2025-08-25 2025-08-25 PrS Proposed sale
3.0
ROELAND NUSSE

Director

Non-Executive Director
17,040
56.36
US$960,388 		17,040 56.36 US$960,388
2025-08-25 2025-08-25 PrS Proposed sale
1.7
ROBERT V. BAUMGARTNER4731 BONITA BAY BOULEVARD

Director

Non-Executive Director
17,040
56.21
US$957,849 		17,040 56.21 US$957,849
2025-06-11 2025-06-09 S Sale
2.2
Herr Amy E.
Non-Executive Director
1,280 -39.3%
49.77
US$63,705 		1,280 -39.3% 49.77 US$63,705
2025-06-09 2025-06-09 PrS Proposed sale
2.2
JOSHUA MOLHO

Officer

Officer
1,280
49.77
US$63,705 		1,280 49.77 US$63,705
2025-02-18 2025-02-14 S Sale
2.2
Herr Amy E.
Non-Executive Director
1,860 -48.5%
65.96
US$122,691 		1,860 -48.5% 65.96 US$122,691
2025-02-14 2025-02-14 PrS Proposed sale
2.2
JOSHUA MOLHO

Domestic Partner of Director

Non-Executive Director
1,860
65.96
US$122,691 		1,860 65.96 US$122,691
2025-01-29 2025-01-27 S Sale
3.7
Kelderman Kim

Chief Executive Officer

Executive Director
1,661 -4.1%
77.95
US$129,480 		1,661 -4.1% 77.95 US$129,480
2025-01-29 2025-01-27 S Sale
3.7
Kelderman Kim

Chief Executive Officer

Executive Director
11,731 -22.4%
77.19
US$905,533 		11,731 -22.4% 77.19 US$905,533
2025-01-27 2025-01-27 PrS Proposed sale
3.7
KIM KELDERMAN

Director; Officer

Executive Director
13,392
77.05
US$1,031,854 		13,392 77.05 US$1,031,854
2024-08-12 2024-08-08 S Sale
1.7
BAUMGARTNER ROBERT V
Non-Executive Director
16,000 -26.9%
72.10
US$1,153,664 		16,000 -26.9% 72.10 US$1,153,664
2024-08-08 2024-08-08 PrS Proposed sale
1.7
ROBERT V. BAUMGARTNER

Director

Non-Executive Director
16,000
72.10
US$1,153,664 		16,000 72.10 US$1,153,664
2024-05-16 2024-05-14 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
4,000 -9.9%
83.84
US$335,377 		4,000 -9.9% 83.84 US$335,377
2024-05-14 2024-05-14 PrS Proposed sale
3.4
JOHN L HIGGINS

Director

Non-Executive Director
4,000
83.84
US$335,377 		4,000 83.84 US$335,377
2024-03-11 2024-03-07 S Sale
3.0
Nusse Roeland
Non-Executive Director
10,400 -19.4%
76.98
US$800,627 		10,400 -19.4% 76.98 US$800,627
2024-03-07 2024-03-07 PrS Proposed sale
3.0
Nusse Roeland

Director

Non-Executive Director
10,400
76.98
US$800,626 		10,400 76.98 US$800,626
2023-09-01 2023-08-30 S Sale
3.0
Nusse Roeland
Non-Executive Director
8,939 -14.7%
80.32
US$717,959 		8,939 -14.7% 80.32 US$717,959
2023-08-30 2023-08-30 PrS Proposed sale
3.0
ROELAND NUSSE

Director

Non-Executive Director
8,939
80.32
US$717,959 		8,939 80.32 US$717,959
2023-07-25 2023-07-21 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
80,000 -6.0%
88.36
US$7,069,024 		80,000 -6.0% 88.36 US$7,069,024
2023-07-21 2023-07-21 PrS Proposed sale
2.8
Kummeth Charles R.

Officer

Officer
80,000
88.36
US$7,069,024 		80,000 88.36 US$7,069,024
2023-06-09 2023-06-07 S Sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
322 -0.0%
83.00
US$26,726 		322 -0.0% 83.00 US$26,726
2023-06-06 2023-06-06 PrS Proposed sale
2.8
Charles Kummeth

Officer

Officer
50,000
83.00
US$4,150,000 		50,000 83.00 US$4,150,000
2022-12-09 2022-12-08 S Sale
2.8
Furlow Brenda S.

SVP - GENERAL COUNSEL

Officer
7,450 -22.2%
82.12
US$611,810 		7,450 -22.2% 82.12 US$611,810
2022-12-09 2022-12-07 S Sale
2.8
Furlow Brenda S.

SVP - GENERAL COUNSEL

Officer
800 -3.0%
82.01
US$65,605 		800 -3.0% 82.01 US$65,605
2022-08-12 2022-08-11 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
8 -0.1%
380.71
US$3,046 		8 -0.1% 380.71 US$3,046
2022-08-12 2022-08-11 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
504 -8.4%
385.47
US$194,277 		504 -8.4% 385.47 US$194,277
2022-08-12 2022-08-10 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
992 -14.2%
380.15
US$377,112 		992 -14.2% 380.15 US$377,112
2022-08-12 2022-08-10 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
100 -1.4%
374.90
US$37,490 		100 -1.4% 374.90 US$37,490
2022-08-12 2022-08-10 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
900 -11.2%
373.99
US$336,593 		900 -11.2% 373.99 US$336,593
2022-06-09 2022-06-08 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
600 -11.5%
366.09
US$219,654 		600 -11.5% 366.09 US$219,654
2022-06-09 2022-06-07 S Sale
2.8
Kummeth Charles R.

CHIEF EXECUTIVE OFFICER

Executive Director
5,104 -2.5%
365.00
US$1,862,960 		5,104 -2.5% 365.00 US$1,862,960
2022-06-09 2022-06-07 S Sale
3.4
HIGGINS JOHN L
Non-Executive Director
1,000 -17.8%
364.31
US$364,310 		1,000 -17.8% 364.31 US$364,310
2022-05-11 2022-05-10 B Purchase
1.7
BAUMGARTNER ROBERT V
Non-Executive Director
300 +3.1%
352.55
US$105,765 		300 +3.1% 352.55 US$105,765
2021-11-23 2021-11-19 S Sale
3.7
Kelderman Kim

Pres. Diagnostics & Genom

Officer
400 -100.0%
505.78
US$202,313 		400 -100.0% 505.78 US$202,313
2021-11-23 2021-11-19 S Sale
3.7
Kelderman Kim

Pres. Diagnostics & Genom

Officer
100 -20.0%
503.76
US$50,376 		100 -20.0% 503.76 US$50,376
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
401 -23.3%
506.24
US$203,002 		401 -23.3% 506.24 US$203,002
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
2,535 -59.6%
505.49
US$1,281,407 		2,535 -59.6% 505.49 US$1,281,407
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
8,989 -67.9%
504.39
US$4,533,985 		8,989 -67.9% 504.39 US$4,533,985
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
9,043 -40.6%
503.61
US$4,554,137 		9,043 -40.6% 503.61 US$4,554,137
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
4,054 -15.4%
502.77
US$2,038,221 		4,054 -15.4% 502.77 US$2,038,221
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
400 -1.5%
505.01
US$202,002 		400 -1.5% 505.01 US$202,002
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
537 -2.0%
504.14
US$270,725 		537 -2.0% 504.14 US$270,725
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
300 -1.1%
502.99
US$150,897 		300 -1.1% 502.99 US$150,897
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
200 -0.7%
504.78
US$100,956 		200 -0.7% 504.78 US$100,956
2021-11-16 2021-11-12 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
700 -2.5%
504.09
US$352,860 		700 -2.5% 504.09 US$352,860
2021-11-03 2021-11-02 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
200 -1.8%
525.10
US$105,020 		200 -1.8% 525.10 US$105,020
2021-11-03 2021-11-01 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
943 -8.1%
528.55
US$498,427 		943 -8.1% 528.55 US$498,427
2021-11-03 2021-11-01 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
1,433 -10.9%
527.50
US$755,903 		1,433 -10.9% 527.50 US$755,903
2021-11-03 2021-11-01 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
2,880 -18.0%
526.50
US$1,516,321 		2,880 -18.0% 526.50 US$1,516,321
2021-11-03 2021-11-01 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
3,566 -18.2%
525.61
US$1,874,318 		3,566 -18.2% 525.61 US$1,874,318
2021-11-01 2021-10-29 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
662 -5.8%
525.23
US$347,704 		662 -5.8% 525.23 US$347,704
2021-11-01 2021-10-28 PlS Planned sale
2.4
Hippel James

Chief Financial Officer

Officer
100 -0.9%
525.18
US$52,518 		100 -0.9% 525.18 US$52,518
2021-09-02 2021-08-31 S Sale
3.6
Eansor Norman David

President-Protein Sciences

Officer
1,538 -53.9%
503.07
US$773,728 		1,538 -53.9% 503.07 US$773,728
2021-09-02 2021-08-31 S Sale
2.8
Furlow Brenda S.

SVP - General Counsel

Officer
3,108 -29.0%
506.12
US$1,573,011 		3,108 -29.0% 506.12 US$1,573,011
2021-09-02 2021-08-31 S Sale
2.8
Furlow Brenda S.

SVP - General Counsel

Officer
1,569 -12.8%
505.26
US$792,755 		1,569 -12.8% 505.26 US$792,755
2021-09-02 2021-08-31 S Sale
2.8
Furlow Brenda S.

SVP - General Counsel

Officer
323 -2.6%
503.24
US$162,546 		323 -2.6% 503.24 US$162,546
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
300 -2.7%
484.98
US$145,494 		300 -2.7% 484.98 US$145,494
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
300 -2.6%
483.62
US$145,085 		300 -2.6% 483.62 US$145,085
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
300 -2.6%
481.61
US$144,482 		300 -2.6% 481.61 US$144,482
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
700 -5.6%
480.66
US$336,462 		700 -5.6% 480.66 US$336,462
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
100 -0.8%
480.70
US$48,070 		100 -0.8% 480.70 US$48,070
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
1,300 -9.4%
479.96
US$623,954 		1,300 -9.4% 479.96 US$623,954
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
1,800 -11.5%
478.58
US$861,444 		1,800 -11.5% 478.58 US$861,444
2021-08-10 2021-08-09 S Sale
2.4
Hippel James

Chief Financial Officer

Officer
5,200 -24.9%
477.69
US$2,484,002 		5,200 -24.9% 477.69 US$2,484,002
2021-06-21 2021-06-18 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
326 -0.2%
450.37
US$146,821 		326 -0.2% 450.37 US$146,821
2021-06-21 2021-06-18 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
2,583 -1.6%
449.09
US$1,159,999 		2,583 -1.6% 449.09 US$1,159,999
2021-06-21 2021-06-17 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
109 -0.1%
452.13
US$49,282 		109 -0.1% 452.13 US$49,282
2021-06-21 2021-06-17 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
1,050 -0.7%
451.54
US$474,117 		1,050 -0.7% 451.54 US$474,117
2021-06-21 2021-06-17 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
1,698 -1.1%
450.39
US$764,762 		1,698 -1.1% 450.39 US$764,762
2021-06-21 2021-06-17 PlS Planned sale
2.8
Kummeth Charles R.

Chief Executive Officer

Executive Director
6,732 -4.0%
449.35
US$3,025,024 		6,732 -4.0% 449.35 US$3,025,024
Explore more

More insider trading research around Bio-Techne Corporation

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America